Free Trial

Benjamin Haynor Analyst Performance

Analyst at Lake Street Capital

Benjamin Haynor is a stock analyst at Lake Street Capital focused in the healthcare sector, covering 6 publicly traded companies. Over the past year, Benjamin Haynor has issued 6 stock ratings, including and buy recommendations. While full access to Benjamin Haynor's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Benjamin Haynor's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
10 Last 1 Years
Buy Recommendations
100.00% 9 Buy Ratings
Companies Covered
6 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%9 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Exchange Coverage

ExchangePercentageCount
NASDAQ
66.7% of companies on NASDAQ
4 companies
NYSE
33.3% of companies on NYSE
2 companies

Benjamin Haynor, an analyst at Lake Street Capital, currently covers 6 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
5 companies
83.3%
Miscellaneous
1 company
16.7%

Benjamin Haynor of Lake Street Capital specializes in stock coverage within the Healthcare sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
HEALTHCARE EQUIPMENT & SUPPLIES
3 companies
50.0%
HEALTHCARE PROVIDERS & SERVICES
2 companies
33.3%
Miscellaneous
1 company
16.7%

Benjamin Haynor's Ratings History at Lake Street Capital

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
11/9/2026Lower Price Target$0.68$1.00Buy
Oncology Institute, Inc. stock logo
STLN
Oncology Institute
11/6/2026Lower Price Target$3.62$8.00Buy
Electromed, Inc. stock logo
ELMD
Electromed
8/26/2026Boost Price Target$34.21$47.00Buy
Femasys Inc. stock logo
FEMY
Femasys
8/18/2026Lower Price Target$2.21$10.00Buy
Femasys Inc. stock logo
FEMY
Femasys
3/3/2026Initiated Coverage$10.27$30.00Buy
Profound Medical stock logo
PROF
Profound Medical
1/7/2026Boost Price Target$7.94$12.00Buy
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
9/22/2025Initiated Coverage$10.14$15.00Buy
Electromed, Inc. stock logo
ELMD
Electromed
8/27/2025Set Price Target$24.66$36.00
Electromed, Inc. stock logo
ELMD
Electromed
8/27/2025Initiated Coverage$24.33$36.00Buy
Profound Medical stock logo
PROF
Profound Medical
4/23/2025Lower Price Target$4.75$11.00Buy